Table 2 Demographic and clinical characteristics of the enrolled subjects for GM metagenomic sequencing in this study

Number

24

9

–

12

9

–

Age (year)

54 ± 7

54 ± 7

0.925

57 ± 6

52 ± 4

0.040*

Height (cm)

153.1 ± 6.1

153.7 ± 7.4

0.822

167.2 ± 6.5

160.9 ± 7.3

0.052

Weight (kg)

58.7 ± 10.1

55.2 ± 11.0

0.395

66.3 ± 9.8

58.9 ± 11.2

0.126

BMI (kg/m2)

25.0 ± 3.7

23.1 ± 2.9

0.190

23.7 ± 2.9

22.7 ± 3.2

0.453

WC (cm)

88.5 ± 9.8

85.1 ± 11.4

0.405

89.2 ± 9.5

82.4 ± 9.3

0.118

SBP (mmHg)

145 ± 17

105 ± 8

0.000*

136 ± 12

112 ± 6

0.000*

DBP (mmHg)

83 ± 9

65 ± 7

0.000*

83 ± 6

69 ± 6

0.000*

MAP (mmHg)

103 ± 9

78 ± 5

0.000*

100 ± 5

83 ± 5

0.000*

FPG (mmol/L)

5.24 ± 1.15

5.38 ± 0.74

0.740

4.58 ± 0.67

4.84 ± 0.88

0.447

TG (mmol/L)

1.71 ± 0.62

1.68 ± 0.83

0.898

1.40 ± 0.78

1.05 ± 0.55

0.255

TC (mmol/L)

4.35 ± 1.14

5.39 ± 1.99 ±

0.068

3.51 ± 0.95

3.62 ± 0.86

0.780

LDL-C (mmol/L)

2.45 ± 0.82

3.36 ± 1.70

0.155

1.88 ± 0.78

2.01 ± 0.63

0.702

HDL-C (mmol/L)

1.26 ± 0.42

1.34 ± 0.46

0.662

1.11 ± 0.44

1.22 ± 0.48

0.559

non-HDL-C (mmol/L)

3.09 ± 0.90

4.05 ± 2.16

0.226

2.40 ± 0.69

2.40 ± 0.77

0.987